| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2b7347cb36e6385cd49190bf5d815bf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17 |
| filingDate |
2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e9c355bd4710b50a2da17e0328e3fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c23bcd722af6fe5faac1e54b892a7cd |
| publicationDate |
2016-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016071446-A1 |
| titleOfInvention |
A veterinary injectable formulation |
| abstract |
A veterinary single injectable formulation comprises buparvaquone and imidocarb or salts thereof. Both active ingredients are completely in solution and therefore bioavailable. The formulation is used in the treatment or prophylaxis of Theileria parasites and/or Anaplasma , Babesia and/or Ehrlichia parasites. The formulation may be administered in an amount of about 1ml per 20kg bodyweight in cattle and horses, or about 1 ml per 10kg bodyweight in calves, foals and dogs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022053584-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2638431-C1 |
| priorityDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |